Position in ELAN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$29,057,248
+$2,467,740 QoQ
Shares Held
1,180,709
+6.3% QoQ
Ownership
0.236%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#60
of 515 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BNP PARIBAS ARBITRAGE, SA holds $502,986,525 across 54 Drug Manufacturers - Specialty & Generic names. ELAN ranks #7 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,415,471 | $101,715,746 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
260,605 | $43,922,366 | |
| 3 | RDY |
Dr Reddys Laboratories Ltd
|
2,649,866 | $38,396,558 | |
| 4 | ALKS |
Alkermes plc.
|
655,140 | $34,329,336 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
300,967 | $33,389,278 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
58,580 | $31,740,401 | |
| 7 | ELAN |
Elanco Animal Health Inc
This page
|
1,180,709 | $29,057,248 | |
| 8 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
437,192 | $27,958,428 |
All Filings in ELAN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,057,248 | 1,180,709 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $26,589,508 | 1,111,137 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $50,984,507 | 2,252,961 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,199,739 | 59,570 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $619,123 | 43,356 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $708,865 | 67,511 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $670,299 | 55,351 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,824,174 | 260,325 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $147,128 | 10,196 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $371,346 | 22,810 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $2,723,094 | 182,758 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,455,636 | 218,473 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $313,077 | 31,121 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $618,802 | 65,830 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,353,829 | 110,788 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,426,603 | 114,956 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $2,109,282 | 107,452 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,198,160 | 84,253 | Shares | Defined | 2022-05-18 | |
| 2021-12-31 | $9,042,776 | 318,632 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $27,597,574 | 865,399 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $9,851,960 | 284,000 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $9,158,037 | 310,969 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $3,927,416 | 128,054 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $5,184,562 | 185,627 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $3,272,068 | 152,544 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $3,677,736 | 164,258 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||